首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Chinese Herbal Medicines

Chinese Herbal Medicines杂志,由Elsevier出版,4 issues/year,出版语言English,ISSN:1674-6384,E-ISSN:1674-6384。

投稿咨询
Chinese Herbal Medicines
Chinese Herbal Medicines
Chinese Herbal Medicines
SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
11.2
CiteScore
13.5
期刊收录
SCIE

Chinese Herbal Medicines(中文译名:《中草药》),ISSN:1674-6384,EISSN:1674-6384,是Elsevier出版的国际性学术期刊,以4 issues/year形式稳定发行,2026年总发文量约69篇。该刊采用非OA开放访问,学科归属为CHEMISTRY, MEDICINAL。该刊是医学、药物化学领域的国际权威刊物,已被SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达11.2,2025年期刊CiteScore为13.5,2025年期刊自引率约2.7%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Chinese Herbal Medicines长期聚焦医学、药物化学及相关产业的技术应用前沿,平均审稿周期10 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药物化学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDIndia、Thailand、Iran、USA、England、Malaysia等为核心发文国家与地区;

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
CHEMISTRY, MEDICINAL 药物化学 INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学
1区 1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
CHEMISTRY, MEDICINAL 药物化学
2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
CHEMISTRY, MEDICINAL 药物化学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL ESCI Q1 4 / 72

95.1

学科:CHEMISTRY, MEDICINAL ESCI Q1 4 / 72

95.14

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL ESCI Q1 17 / 72

77.1

学科:CHEMISTRY, MEDICINAL ESCI Q3 38 / 72

47.92


中国学者近期发文

1
Diverse alkaloids with anti-inflammatory activity discovered from Thalictrum baicalens

Author:Yang, Jinyuan; Chen, Zhaojing; Xue, Jingjing; Ren, Yikun; Li, Zhanlin; Li, Dahong; Sun, Yating; Hua, Huiming

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 487-490. DOI: 10.1016/j.chmed.2026.02.013

2
Efficacy and safety of Toujie Quwen Granules in patients infected with SARS-CoV-2: A prospective cohort study of 156 case

Author:Xu, Qihua; Zhang, Xinyue; Huang, Sanqi; Li, Linghua; Li, Feng; Liu, Wei; Ling, Kunzhou; Guan, Jialong; Tan, Xinghua; Lin, Luping

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 303-311. DOI: 10.1016/j.chmed.2026.02.016

3
Anti-influenza formula medicines based on warm disease theory of traditional Chinese medicin

Author:Xiao, Mengjie; Huang, Tao; Qin, Shengle; Zhang, Tianbo; Li, Runfeng; Zhao, Xin; Lin, Luping; Yang, Zifeng

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 231-240. DOI: 10.1016/j.chmed.2026.02.008

4
Biosynthetic pathway analysis of ginsenoiside Rh1 to notoginsenoside R

Author:Wang, Rubing; Zhang, Yanan; Zhang, Huanyu; Yang, Wenqi; Su, Yaowu; Jing, Hongyan; Wang, Juan; Gao, Wenyuan

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 484-486. DOI: 10.1016/j.chmed.2026.02.001

5
Future prospects of antiviral research in traditional Chinese medicin

Author:Wang, Kexin; Yang, Zifeng

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 226-230. DOI: 10.1016/j.chmed.2026.02.014

6
Shuxuening injection for acute ischemic stroke: Efficacy and safety-a randomized, double-blind, placebo controlled, multi-center clinical tria

Author:Ma, Ruihong; Li, Xiaogang; An, Xiaolei; Li, Juntao; Zhu, Jianguo; Temuqile; Zhan, Liping; Zhou, Peiyang; Ren, Baolong; Wang, Baoai; Sun, Yuanyuan; Xiao, Wei; Xu, Men

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 461-469. DOI: 10.1016/j.chmed.2024.12.004

7
Integrated network pharmacology and metabolomics to analyze the mechanism of Shaofu Zhuyu Decoction in treatment of dysmenorrhea of cold coagulation and blood stasi

Author:Luo, Yilu; Wu, Zengguang; Ji, Ruifeng; Shen, Lingling; He, Xin

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 420-438. DOI: 10.1016/j.chmed.2025.02.002

8
Optimization of imperatorin extraction from Qianliexin Capsules using deep eutectic solven

Author:Liu, Cejia; Bai, Hezheng; Liu, Jianxiang; Zhou, Xunyong; Liang, Ning; Shen, Tao; Zhao, Longshan

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 452-460. DOI: 10.1016/j.chmed.2025.03.005

9
Rhein/Fe3+ nanoassembly for triple-negative breast cancer treatment via a ferroptosis and immunogenic deat

Author:Liang, Shuntao; Gan, Licheng; Tao, Xiaomei; Xia, Fei; Tu, Qingchao; Zhong, Linying; Fu, Yuanfeng; Liu, Yinan; Meng, Yuqing; Shi, Qiaoli; Zhang, Junzhe; Wang, Jigang; Qiu, Chong

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 481-483. DOI: 10.1016/j.chmed.2026.02.012

10
Combined network pharmacology and biological verification to investigate anti-influenza A virus effect and potential mechanism of Pudilan Xiaoyan Oral Liqui

Author:Li, Hualing; Wang, Wenlei; Zheng, Zhihui; Zhang, Yuqian; Li, Danting; Su, Qin; Wei, Hailin; Wang, Zehua; Min, Rui; Zhang, Xinyue; Chen, Zihan; Wang, Xiaoquan; Zhang, Pinghu

Journal: CHINESE HERBAL MEDICINES. 2026; Vol. 18, Issue 2, pp. 262-271. DOI: 10.1016/j.chmed.2025.04.004


在线咨询

Chinese Herbal Medicines

国际简称:CHIN HERB MED参考译名:中草药

年发文量:69 CiteScore:13.5 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:68.12%
Chinese Herbal Medicines